| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner, Director By Deputization | 10% Owner, Possible Member Of 10% Group | Director, 10% Owner, * Director By Deputization +10 more
38 companies
Flynn James E is a 10% Owner, *possible Member Of 10% Group at AHCO with holdings across 38 companies. Recent SEC Form 4 filings include 5 buys and 19 sells.
Estimated insider holdings value: $955.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2016 | AXGN Axogen, Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 102,136 | $6.70 | $684,311.20 | -3.3% | |
| Jul 20, 2016 | LRMR Larimar Therapeutics, Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 1,341,499 | $3.31 | $4,442,776.39 | -43.9% | |
| Jul 18, 2016 | AXGN Axogen, Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 279,303 | $7.53 | $2,104,170.91 | -2.9% | |
| Jul 6, 2016 | SYRS Syros Pharmaceuticals, Inc. | 10% Owner, Possible Members Of 10% Group | Buy | 400,000 | $12.50 | $5,000,000.00 | +23.6% | |
| Jun 21, 2016 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 204,854 | $14.21 | $2,911,063.12 | -12.3% | |
| Jun 14, 2016 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 43,300 | $13.88 | $601,168.54 | -4.5% | |
| Jun 8, 2016 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 63,736 | $13.92 | $887,049.16 | -2.1% | |
| Jun 2, 2016 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 99,508 | $13.85 | $1,378,434.98 | -3.0% | |
| May 27, 2016 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 212,581 | $14.13 | $3,002,905.92 | -5.5% | |
| Feb 12, 2016 | LRMR Larimar Therapeutics, Inc. | 10% Owner, Possible Member Of 10% Group | Buy | 64,545 | $6.25 | $403,186.80 | +2.2% |